Position in VYGR
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$4,656,722
+$603,808 QoQ
Shares Held
1,330,492
+26.7% QoQ
Ownership
2.16%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#6
of 135 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VYGR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $22,039,427,018 across 520 Biotechnology names. VYGR ranks #251 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in VYGR
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,656,722 | 1,330,492 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $4,052,914 | 1,049,978 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $4,461,288 | 1,135,188 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $5,364,017 | 1,148,612 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $3,473,393 | 1,116,847 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $3,734,622 | 1,104,918 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $6,147,629 | 1,084,238 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $6,315,127 | 1,079,509 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $8,485,601 | 1,072,769 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $9,052,708 | 972,364 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $5,729,730 | 678,878 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $5,013,823 | 646,945 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $6,758,419 | 590,255 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $2,106,796 | 273,255 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,663,701 | 272,738 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,604,450 | 271,022 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,599,967 | 270,722 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $2,009,371 | 263,697 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $953,822 | 351,964 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $732,838 | 278,646 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $1,148,660 | 278,126 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $2,189,292 | 464,818 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $2,800,340 | 391,656 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $4,232,180 | 396,643 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $5,111,150 | 405,004 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $3,626,291 | 396,316 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||